Abstract [eng] |
Title. Mood Disorders and Suicidal Ideations in Patients, Attending Community Pharmacy, and Their Attitude Towards Community Pharmacist-provided Consultation Regarding Mood Disorders Aim was to evaluate mood disorders (MD) and suicidal ideation (SI) in patients, attending community pharmacy (PCP) during routine visits (DRV), and their attitude towards community pharmacist-provided consultation regarding MS Objectives. 1. Evaluate sociodemographic data of PCP DRV and attitude towards their mood. 2. Evaluate the frequency of MD and SI in PCP DRV, recognised by community pharmacists (CP) using the PHQ-9 questionnaire. 3. Evaluate attitude of PCP DRV towards CP provided consultation regarding MD. 4. Evaluate the association between sociodemographic data of PCP DRV and their attitude towards CP provided consultation regarding MD. Method. Cross-sectional study. 336 PCP DRV, of which 175 (52.9%) were female and 161 (47.9%) were male. An anonymous survey was conducted, which consisted of three parts: a sociodemographic questionnaire, the PHQ-9 questionnaire, and questions about attitude towards CP provided consultation regarding MD Results. There were significantly fewer widowed and divorced men than women, n=4 (2.5%) vs n=14 (8.0%); n=11 (6.8%) vs n=23 (13.1%), (p=0.023). 92 of PCP had minor children (MC+) and 244 did not (MC-). n=48/344 (14.4%) felt symptoms of depression during the study, of which n=8 (33.3%) men vs n=25 (73.5%) women reported depressive mood, (p=0.003). Anti-anxiety drugs were reported by n=4 (2.7%) men vs n=13 (8.7%) women, (p=0.049). According to PHQ-9, 47 (14.1%) patients experienced depressive symptoms (DS+), 287 (85.9%) patients did not experience depressive symptoms (DS-). 20 patients experienced SI. The mean age of DS+ differed from DS- (40.2±19 vs 46.7±15.7), (p=0.011). A negative correlation was found between PHQ-9 and patients age (r=-0.178), (p<0.01). DS+ rated the statement about the friendliness of CP regarding MD better than DS-, (3.4±0.7/5 vs 3.0±0.9/5) (p=0.008). PHQ-9 score negatively correlated with statement about CP's knowledge about MD and ability to recognize MD, respectively (r=-0.115), (p<0.05); (r=-0.135), (p<0.05). The worst rated statements were about talking to CP about MD and expressing depressive thoughts to CP, respectively 2.6±1/5; 2.6±1/5. The best rated statements were about CP's explanation of drugs usage and CP's maintenance of confidentiality regarding health problems, respectively 4.2±0.7/5; 4.0±0.9/5. MV+ rated the statements worse than MV- regarding CP's knowledge about MD 3.2±0.8/5 vs 3.4±0.9/5, (p=0.021); CP's recognition of MD 3.1±0.6/5 vs 3.3±0.9/5, (p=0.010); disclosure of depressive feelings to CPs 2.3±0.9/5 vs 2.7±1.0/5, (p=0.003); and calmness when discussing MD with CP 2.4±0.9/5 vs 2.7±1.0/5, (p=0.004); CP's friendly perception of MD 2.7±0.9/5 vs 3.2±0.9/5 (p=0.00005); fear of talking about MD with CPs 2.5±0.9/5 vs 2.8±1.0/5 (p=0.010) Conclusions. 1. Sociodemographic data of PCP DRV, did not differ. The attitude of PCP DRV, towards their mood did not differ. 2. One-seventh of PCP DRV, had MD, with most experiencing moderate depressive symptoms and the fewest experiencing severe depressive symptoms. Twenty patients experienced SI. The younger the patients, the higher their PHQ-9 score, and the poorer their perception of CP knowledge and ability to recognize patients with MD. 3. The attitude of PCP DRV towards CP was rated avarage. CP‘s ability to explain medication usage was rated the highest (above 4/5), while trust in CP compared to physicians when discussing depressive mood was rated the lowest (above 2/5). 4. When evaluating the associations between the attitude and sociodemographic data of PCP DRV, a significant difference was found between those who had minor children and those who did not, in terms of their perception of CP‘s knowledge and ability to recognize patients with MD, as well as in comparing CP to physicians when discussing depressive mood. |